Agreement is next step to provide AI based healthcare services in Africa

Mauldin, SC., March 29, 2023 —Xcelerate, Inc. (OTCQB: “XCRT”) today, announced that Afya Sasa Africa LLC, a subsidiary of Xcelerate signed an Agreement to implement its Artificial Intelligence (AI) based health services at Haydom Regional Rural Referral Hospital, also known as Haydom Lutheran Hospital (“HLH”) in Haydom, Tanzania. HLH is a 420-bed hospital serving 5.7 million people in North Central Tanzania. HLH provides for 12,635 inpatient admissions and 103,173 outpatient visits annually.

Dr. Dilan Ellegala, Senior Member of the Company’s Advisory Board and Co- Founder of Afya Sasa Africa commented “This is our chance to demonstrate the effectiveness of our platform for large regional ref hospitals serving remote rural communities.”

“This Agreement, our second in three weeks, is the culmination of one and a half years of work by the Afya Sasa team, as funded by Xcelerate, and we anticipate commencement of a revenue stream from this project by Q4 of 2023. Our business model projects revenue to come from multiple sources including member fees, technology (hospital) fees, prescription fees and virtual consultation fees (as a % of billings by the provider) as well as nationwide National Health System underwriting commitments once the system is fully integrated” commented Mike O’Shea, CEO of Xcelerate.

“Afya Sasa leverages the power of advanced artificial intelligence to assist the clinician in the proper diagnosis, testing, and treatment to enhance the effectiveness and efficiency of clinicians while providing the patient enhanced access to state-of- the-art care in line with the goals of the Government of Tanzania. Afya Sasa Africa can be customized to disease prevalence’s by country and even to specific regions within a country and can be accessible in English and Swahili. We believe Artificial Intelligence and Afya Sasa’s System can bridge the gap in unmet healthcare need in the developing world” notes Sri Perera, Afya Sasa Tanzania Managing Director.

The Afya Sasa system is powered by AdviNOW Medical and Afya Sasa has executed exclusive rights agreements for 10 initial priority markets across Africa including Tanzania, Kenya, Ethiopia, Uganda, Malawi, Zambia, Ghana, Zimbabwe, Botswana, South Africa and Egypt, representing a total catchment of 1 billion people.


In May 2020, Xcelerate commenced implementation of a new business plan that encompasses two separate but related businesses within the medical industry, including (i) owning and licensing the rights to various forms of medical equipment and portfolio of patents, patents pending and technology licenses and (ii) development of virtual health technology to assist patients in developing countries initially in Africa to provide for their population to obtain medical care by extending the reach of physicians through the use of that technology.


This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) the Company’s financing plans; (ii) trends affecting the Company’s financial condition or results of operations; (iii) the Company’s growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words “may,” “would,” “will,” “expect,” “estimate,” “anticipate,” “believe,” “intend,” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control, and actual results may differ materially from those projected in forward-looking statements resulting from various factors.

For more information:
Michael O’Shea, CEO, at 854-900-2020 email:

Leave a Reply

Your email address will not be published. Required fields are marked *